Penerangan
Olprinone ialah perencat selektif phosphodiesterase 3 (PDE3). Olprinone digunakan sebagai agen kardiotonik dengan kesan inotropik dan vasodilatasi positif. Olprinone telah dilaporkan meningkatkan peredaran mikro dan melemahkan keradangan. Olprinone sering digunakan untuk meningkatkan output jantung selepas pintasan kardiopulmonari (CPB). Olprinone diselitkan pada kadar 0.2 μg/kg/min apabila penyapihan daripada CPB dimulakan. Olprinone juga telah menunjukkan kesan antioksidan dan anti-radang yang kuat dalam kecederaan paru-paru oksidatif yang disebabkan oleh meconium.
Informasi teknikal:
sinonim: Olprinonehydrochloride-Loprinonehydrochloride;3-pyridinecarbonitrile,1,2-dihydro-5-(imidazo(1,2-a)piridin-6-yl)-6-metil-2-o;e1020;xo-,monohidroklorida,monohidrat;OLPRINONEHCL;
Sijil: sijil GMP, CFDA
Formula Molekul: C14H10N4O • HCl
Berat Formula :286.7
Ketulenan: ≥98%
Formulasi(Minta perubahan formulasi)
SENYUMAN Canonical: CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2.Cl
Maklumat Penghantaran & Penyimpanan:
Penyimpanan: -20°C
Penghantaran: Suhu Bilik di benua AS; mungkin berbeza di tempat lain
Kestabilan: ≥ 4 tahun
Baca Berita Terkini Kami

Jun.11,2025
Washing Resistance of 6-Amino-1,3-dimethyl-5-nitrosouracil in UV-Resistant Fabrics
The textile industry's pursuit of durable ultraviolet protection has led to the adoption of sophisticated chemical compounds originally developed for pharmaceutical applications.
Baca Lagi
Jun.11,2025
The Role of 6-Amino-1,3-dimethyluracil in the Biocatalytic Synthesis of Caffeine
The synthesis of complex alkaloids like caffeine represents one of the most sophisticated applications of modern pharmaceutical intermediates manufacturing.
Baca Lagi
Jun.11,2025
The Role of 6-Amino-1,3-dimethyluracil as a Pharmaceutical Intermediate in the Synthetic Route of Caffeine
The world of modern pharmaceutical manufacturing relies heavily on specialized chemical compounds known as pharmaceutical intermediates, which serve as crucial building blocks in the multistep synthesis of active drug ingredients.
Baca Lagi